Announcements Trials
Browse Landscape

Phase

Phase NA 21Phase EARLY_PHASE1 1Phase 2 1Phase 1/2 1

Status

Unknown 17Completed 14Recruiting 7Not yet recruiting 7Active not recruiting 3Terminated 2Suspended 2Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 3Carcinoma, Transitional Cell 2Breast Neoplasms 2Thyroid Diseases 1Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Pituitary Neoplasms 1Parathyroid Neoplasms 1Muscle Invasive Bladder Urothelial Carcinoma 1Lung Neoplasms 1Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype 1Esophageal Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Castration-Resistant Prostate Cancer (CRPC) 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Enrolling by invitation × Colorectal Neoplasms × Clear all
NCT06434376 2026-04-28

MRD-positive Colorectal Cancer Patients Combined With Personalized Immune Regulation Diagnosis

Second Affiliated Hospital of Wenzhou Medical University

Phase EARLY_PHASE1 Enrolling by invitation
10 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡